ES2154398T3 - Piridinas 2,3-sustituidas para el tratamiento de la inflamacion. - Google Patents
Piridinas 2,3-sustituidas para el tratamiento de la inflamacion.Info
- Publication number
- ES2154398T3 ES2154398T3 ES96904505T ES96904505T ES2154398T3 ES 2154398 T3 ES2154398 T3 ES 2154398T3 ES 96904505 T ES96904505 T ES 96904505T ES 96904505 T ES96904505 T ES 96904505T ES 2154398 T3 ES2154398 T3 ES 2154398T3
- Authority
- ES
- Spain
- Prior art keywords
- sup
- inflammation
- substituted
- treatment
- alquiltio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE DESCRIBE UNA CLASE DE COMPUESTOS PIRIDIL SUSTITUIDOS PARA EL TRATAMIENTO DE LA INFLAMACION Y DE LOS TRASTORNOS RELACIONADOS CON LA INFLAMACION. LOS COMPUESTOS DE PARTICULAR INTERES SE DEFINEN POR LA FORMULA (II), DONDE R{SUP,1} SE SELECCIONA DE ENTRE HIDRIDO, HALO, ALCOXI, HALOALCOXI, ARILO, ALQUILTIO, ALQUILAMINO, ARALCOXI, AZIDO Y ALQUENILOXI; DONDE R{SUP,2} SE SELECCIONA A PARTIR DE HIDRIDO, CIANO, HIDROXIALQUILO, HALOALQUILO, AMINOALQUILO, ALQUILAMINOALQUILO, ALQUILCARBONILOXIALQUILO, AMINOCARBONILO Y ALQUILCARBONILAMINOALQUILO; Y DONDE R{SUP,5} Y R{SUP,6} SON UNO O MAS RADICALES SELECCIONADOS INDEPENDIENTEMENTE ENTRE HALO, ALQUILSULFONILO, AMINOSULFONILO, ALCOXI Y ALQUILTIO; SIEMPRE QUE UNO DE R{SUP,5} Y R{SUP,6} SEAN SUSTITUIDOS CON ALQUILSULFONILO, AMINOSULFONILO O HALOALQUILSULFONILO; O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/387,150 US5686470A (en) | 1995-02-10 | 1995-02-10 | 2, 3-substituted pyridines for the treatment of inflammation |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2154398T3 true ES2154398T3 (es) | 2001-04-01 |
Family
ID=23528689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96904505T Expired - Lifetime ES2154398T3 (es) | 1995-02-10 | 1996-02-08 | Piridinas 2,3-sustituidas para el tratamiento de la inflamacion. |
Country Status (10)
Country | Link |
---|---|
US (2) | US5686470A (es) |
EP (1) | EP0808304B1 (es) |
AT (1) | ATE198327T1 (es) |
AU (1) | AU4859396A (es) |
DE (1) | DE69611354T2 (es) |
DK (1) | DK0808304T3 (es) |
ES (1) | ES2154398T3 (es) |
GR (1) | GR3035199T3 (es) |
PT (1) | PT808304E (es) |
WO (1) | WO1996024584A1 (es) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6512121B2 (en) | 1998-09-14 | 2003-01-28 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
AU2250097A (en) * | 1996-02-13 | 1997-09-02 | G.D. Searle & Co. | Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist |
US5861419A (en) | 1996-07-18 | 1999-01-19 | Merck Frosst Canad, Inc. | Substituted pyridines as selective cyclooxygenase-2 inhibitors |
SK283261B6 (sk) * | 1996-07-18 | 2003-04-01 | Merck Frosst Canada & Co. / Merck Frosst Canada & Cie. | Substituované pyridíny, farmaceutický prostriedok s ich obsahom a ich použitie |
EP1479385B1 (en) | 1996-10-15 | 2008-07-02 | G.D. Searle LLC | Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
US6096753A (en) * | 1996-12-05 | 2000-08-01 | Amgen Inc. | Substituted pyrimidinone and pyridone compounds and methods of use |
US6410729B1 (en) | 1996-12-05 | 2002-06-25 | Amgen Inc. | Substituted pyrimidine compounds and methods of use |
US6004960A (en) * | 1997-03-14 | 1999-12-21 | Merck Frosst Canada, Inc. | Pyridazinones as inhibitors of cyclooxygenase-2 |
ATE271547T1 (de) * | 1997-03-14 | 2004-08-15 | Merck Frosst Canada Inc | Pyridazinone als inhibitoren von cyclooxygenase-2 |
TW492959B (en) * | 1997-04-18 | 2002-07-01 | Merck & Co Inc | Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors |
US6130334A (en) * | 1998-04-15 | 2000-10-10 | Merck & Co., Inc. | Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitors |
US6127545A (en) * | 1997-04-18 | 2000-10-03 | Merck & Co., Inc. | Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitors |
US6307047B1 (en) | 1997-08-22 | 2001-10-23 | Abbott Laboratories | Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
US6525053B1 (en) | 1997-08-22 | 2003-02-25 | Abbott Laboratories | Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
US6004950A (en) * | 1997-09-12 | 1999-12-21 | Merck Frosst Canada, Inc. | 2-aminopyridines as inhibitors of cyclooxygenase-2 |
US6046217A (en) * | 1997-09-12 | 2000-04-04 | Merck Frosst Canada & Co. | 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2 |
DE69825603T2 (de) * | 1997-09-12 | 2005-07-28 | Merck Frosst Canada & Co, Kirkland | 2,3,5-trisubstituierte pyridine als inhibitoren von cyclooxygenase-2 |
US6040450A (en) * | 1997-09-25 | 2000-03-21 | Merck & Co., Inc. | Process for making diaryl pyridines useful as cox-2-inhibitors |
AR015938A1 (es) * | 1997-09-25 | 2001-05-30 | Merck Sharp & Dohme | Procedimiento para preparar diaril piridinas utiles como inhibidores cox-2 y compuesto intermediario |
US6022884A (en) | 1997-11-07 | 2000-02-08 | Amgen Inc. | Substituted pyridine compounds and methods of use |
US6025353A (en) * | 1997-11-19 | 2000-02-15 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
CN1284945A (zh) * | 1997-12-19 | 2001-02-21 | 安姆根有限公司 | 取代的吡啶和哒嗪化合物及其药物用途 |
US6174901B1 (en) * | 1998-12-18 | 2001-01-16 | Amgen Inc. | Substituted pyridine and pyridazine compounds and methods of use |
US6649645B1 (en) | 1998-12-23 | 2003-11-18 | Pharmacia Corporation | Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia |
JP2003523954A (ja) | 1999-12-08 | 2003-08-12 | ファルマシア コーポレイション | 治療効果が迅速に開始されるシクロオキシゲナーゼ−2阻害剤組成物 |
WO2001081333A2 (en) * | 2000-04-25 | 2001-11-01 | Pharmacia Corporation | Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes |
AU2001275004A1 (en) * | 2000-06-01 | 2001-12-11 | Pharmacia Corporation | Use of cox2 inhibitors for treating skin injury from exposure to ultraviolet radiation |
CA2414674A1 (en) * | 2000-07-13 | 2002-01-24 | Pharmacia Corporation | Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
NZ523998A (en) | 2000-08-11 | 2005-07-29 | Eisai Co Ltd | 2-aminopyridine compounds and use thereof as drugs |
WO2002055502A1 (en) * | 2001-01-02 | 2002-07-18 | Fujisawa Pharmaceutical Co., Ltd. | Pyridine derivatives useful as cyclooxygenase inhibitor |
US7115565B2 (en) * | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
US7695736B2 (en) | 2001-04-03 | 2010-04-13 | Pfizer Inc. | Reconstitutable parenteral composition |
US6673818B2 (en) | 2001-04-20 | 2004-01-06 | Pharmacia Corporation | Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation |
UA80682C2 (en) * | 2001-08-06 | 2007-10-25 | Pharmacia Corp | Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition |
AR038957A1 (es) | 2001-08-15 | 2005-02-02 | Pharmacia Corp | Terapia de combinacion para el tratamiento del cancer |
US7271266B2 (en) * | 2002-03-28 | 2007-09-18 | Merck & Co., Inc. | Substituted 2,3-diphenyl pyridines |
US7329401B2 (en) | 2002-04-15 | 2008-02-12 | The Regents Of The University Of California | Cyclooxygenase-2 selective agents useful as imaging probes and related methods |
GB0221443D0 (en) * | 2002-09-16 | 2002-10-23 | Glaxo Group Ltd | Pyridine derivates |
CN1809536A (zh) * | 2003-04-24 | 2006-07-26 | 麦克公司 | Akt活性抑制剂 |
WO2004096131A2 (en) * | 2003-04-24 | 2004-11-11 | Merck & Co., Inc. | Inhibitors of akt activity |
AU2004237439B2 (en) * | 2003-05-07 | 2009-09-10 | Osteologix A/S | Treating cartilage/bone conditions with water-soluble strontium salts |
CA2524610C (en) * | 2003-05-07 | 2014-03-25 | Osteologix A/S | Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions |
ES2229928B1 (es) * | 2003-10-02 | 2006-07-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de pirimidin-2-amina. |
ES2241496B1 (es) * | 2004-04-15 | 2006-12-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridina. |
US7271383B2 (en) * | 2004-08-11 | 2007-09-18 | Lexmark International, Inc. | Scanning system with feedback for a MEMS oscillating scanner |
FR2876691B1 (fr) * | 2004-10-18 | 2006-12-29 | Sanofi Aventis Sa | Derives de pyridine, leur preparation, leur application en therapeutique |
ES2270715B1 (es) * | 2005-07-29 | 2008-04-01 | Laboratorios Almirall S.A. | Nuevos derivados de pirazina. |
ES2274712B1 (es) * | 2005-10-06 | 2008-03-01 | Laboratorios Almirall S.A. | Nuevos derivados imidazopiridina. |
FR2899899A1 (fr) * | 2006-04-14 | 2007-10-19 | Sanofi Aventis Sa | Derives d'aminomethyl pyridine, leur preparation et leur application en therapeutique |
ES2303776B1 (es) * | 2006-12-29 | 2009-08-07 | Laboratorios Almirall S.A. | Derivados de 5-fenil-6-piridin-4-il-1,3-dihidro-2h-imidazo(4,5-b)piridin-2-ona utiles como antagonistas del receptor de adenosina a2b. |
CN101626787A (zh) * | 2007-01-19 | 2010-01-13 | 马林克罗特公司 | 诊断的和治疗的环氧合酶-2结合配体 |
FR2922209B1 (fr) * | 2007-10-12 | 2010-06-11 | Sanofi Aventis | 5,6-DIARYLES PYRIDINES SUBSTITUES EN POSITION 2 et 3, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE. |
CN109851538B (zh) * | 2019-02-18 | 2020-12-04 | 浙江师范大学 | 一种制备γ-芳基腈的方法及化合物 |
CN112174861B (zh) * | 2020-10-04 | 2022-12-27 | 浙江师范大学 | 一种制备α-芳基腈的方法及化合物 |
WO2022195579A1 (en) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases |
CN115260092B (zh) * | 2022-08-23 | 2023-08-25 | 山东京博生物科技有限公司 | 一种2-氯烟酰胺及其n取代衍生物的合成方法 |
US11926609B1 (en) | 2023-10-13 | 2024-03-12 | King Faisal University | 6′-(3-chlorophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile as antimicrobial compounds |
US11958826B1 (en) | 2023-10-13 | 2024-04-16 | King Faisal University | 6′-(2-chlorophenyl)-2′-ethoxy-3,4′-bipyridine-3′- carbonitrile as an antimicrobial compound |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL6816241A (es) * | 1967-12-01 | 1969-06-03 | ||
US3655679A (en) * | 1969-06-25 | 1972-04-11 | Merck & Co Inc | Certain aryl pyridine carboxylic acid derivatives |
FR2248027B2 (es) * | 1973-10-18 | 1977-09-09 | Serdex | |
US4495202A (en) * | 1983-06-22 | 1985-01-22 | Eli Lilly And Company | Terphenyl derivatives and pharmaceutical uses thereof |
US4533666A (en) * | 1983-06-22 | 1985-08-06 | Eli Lilly And Company | 6-Phenyl-2,3-bis-(4-methoxyphenyl)-pyridine derivatives having anti-inflammatory activity |
EP0308020A3 (en) * | 1987-09-18 | 1990-12-05 | Merck & Co. Inc. | 5-(aryl and heteroaryl)-6-(aryl and heteroaryl)-1,2-dihydro-2-oxo 3-pyridinecarboxylic acids and derivatives thereof |
ES2058625T3 (es) * | 1989-03-22 | 1994-11-01 | American Cyanamid Co | Metodo para la oxidacion secuencial de quinolinas sustituidas para producir acidos piridin-2,3-dicarboxilicos sustituidos. |
US5225418A (en) * | 1991-12-17 | 1993-07-06 | Du Pont Merck Pharmaceutical Company | 5H-(1,2)benzisothiazolo[2,3-a]quinoline-5-ones and analogs as antiinflammatory agents |
US5593994A (en) * | 1994-09-29 | 1997-01-14 | The Dupont Merck Pharmaceutical Company | Prostaglandin synthase inhibitors |
-
1995
- 1995-02-10 US US08/387,150 patent/US5686470A/en not_active Expired - Fee Related
-
1996
- 1996-02-08 US US08/894,102 patent/US5916905A/en not_active Expired - Fee Related
- 1996-02-08 AT AT96904505T patent/ATE198327T1/de not_active IP Right Cessation
- 1996-02-08 DE DE69611354T patent/DE69611354T2/de not_active Expired - Fee Related
- 1996-02-08 AU AU48593/96A patent/AU4859396A/en not_active Abandoned
- 1996-02-08 EP EP96904505A patent/EP0808304B1/en not_active Expired - Lifetime
- 1996-02-08 DK DK96904505T patent/DK0808304T3/da active
- 1996-02-08 PT PT96904505T patent/PT808304E/pt unknown
- 1996-02-08 ES ES96904505T patent/ES2154398T3/es not_active Expired - Lifetime
- 1996-02-08 WO PCT/US1996/001111 patent/WO1996024584A1/en active IP Right Grant
-
2001
- 2001-01-10 GR GR20010400017T patent/GR3035199T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5916905A (en) | 1999-06-29 |
US5686470A (en) | 1997-11-11 |
PT808304E (pt) | 2001-06-29 |
EP0808304A1 (en) | 1997-11-26 |
WO1996024584A1 (en) | 1996-08-15 |
AU4859396A (en) | 1996-08-27 |
GR3035199T3 (en) | 2001-04-30 |
DK0808304T3 (da) | 2001-01-29 |
EP0808304B1 (en) | 2000-12-27 |
DE69611354T2 (de) | 2001-06-07 |
DE69611354D1 (de) | 2001-02-01 |
ATE198327T1 (de) | 2001-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2154398T3 (es) | Piridinas 2,3-sustituidas para el tratamiento de la inflamacion. | |
ES2183884T3 (es) | Compuestos de imidazolilo sustituidos en 4,5 para el tratamiento de la inflamacion. | |
CO4290353A1 (es) | Agonistas de estrogeno | |
AR003955A1 (es) | Derivados de n-(indol-2-carbonil)-glicinamidas, procedimiento para su obtencion y composiciones que los contienen. | |
ES2145922T3 (es) | Compuestos espiro-azabiciclicos utiles en terapia. | |
DE3162445D1 (de) | 3-aryloxy-3-phenylpropylamines | |
SE8404019D0 (sv) | Oftalmiskt medel | |
NO912630L (no) | Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler som antiarteriosklerotiske midler | |
ES2123149T3 (es) | Derivados de perhidroisoindol como antagonistas de la substancia p. | |
LU90752I2 (fr) | Panretin-alitretinoin et ses d-riv-s pharmaceutiquement acceptables | |
NO160579C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-(1,4,5-trifenylimidazol-2-yloksy)-alkansyrer og disses derivater. | |
MX9302461A (es) | Benzo-y piridopiridonas sustituidas por sulfonilbencilo, procedimiento para su obtencion y medicamentos que las contienen. | |
NO954609D0 (no) | Niopecotiske syrederivater som antitrombiske forbindelser | |
ES2176321T3 (es) | Derivados tetrasustituidos del imidazol, su procedimiento de preparacion, su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen. | |
BR8305838A (pt) | Composicao herbicidas, contendo derivados de ciclohexano - 1,3 - diona, e processo para preparacao destes derivados | |
ES2074508T3 (es) | Benzocicloalquilaminopiridinaminas y compuestos afines, un procedimiento e intermediarios para su preparacion y su uso como medicamentos. | |
BR9612074A (pt) | Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas | |
ES2168355T3 (es) | Derivados de bisulfuro de indano-2-mercaptoacetilamida utiles como inhibidores de la encefalinasa. | |
PT89029A (pt) | Processo para a preparacao de novos derivados substituidos de 20,21-dinoreburnamenina | |
DK467983A (da) | Mikroporoes ferrosilicat og fremgangsmaade til fremstilling af samme | |
ES2053686T3 (es) | Nuevos di(met)acrilatos, procedimiento para su fabricacion y su empleo. | |
ATE25247T1 (de) | 4-amino-3-imidazolin-2-on und (2-methoxy-2-imino- ethyl)-harnstoff, ihre herstellung und verwendung. | |
ES2035105T3 (es) | Procedimiento para la preparacion de n-alquil derivados de 2-amino-6,7-dimetoxi tetralina. | |
SE8700566L (sv) | Tetracykliska kinazolinoner | |
ES2108439T3 (es) | Procedimiento para preparar triazoles biciclicos herbicidas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 808304 Country of ref document: ES |